244 related articles for article (PubMed ID: 22711709)
1. Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel.
de Graan AJ; Lancaster CS; Obaidat A; Hagenbuch B; Elens L; Friberg LE; de Bruijn P; Hu S; Gibson AA; Bruun GH; Corydon TJ; Mikkelsen TS; Walker AL; Du G; Loos WJ; van Schaik RH; Baker SD; Mathijssen RH; Sparreboom A
Clin Cancer Res; 2012 Aug; 18(16):4433-40. PubMed ID: 22711709
[TBL] [Abstract][Full Text] [Related]
2. Contribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearance.
Lee HH; Leake BF; Teft W; Tirona RG; Kim RB; Ho RH
Mol Cancer Ther; 2015 Apr; 14(4):994-1003. PubMed ID: 25695959
[TBL] [Abstract][Full Text] [Related]
3. Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide.
Zimmerman EI; Hu S; Roberts JL; Gibson AA; Orwick SJ; Li L; Sparreboom A; Baker SD
Clin Cancer Res; 2013 Mar; 19(6):1458-66. PubMed ID: 23340295
[TBL] [Abstract][Full Text] [Related]
4. Influence of drug formulation on OATP1B-mediated transport of paclitaxel.
Nieuweboer AJ; Hu S; Gui C; Hagenbuch B; Ghobadi Moghaddam-Helmantel IM; Gibson AA; de Bruijn P; Mathijssen RH; Sparreboom A
Cancer Res; 2014 Jun; 74(11):3137-45. PubMed ID: 24755470
[TBL] [Abstract][Full Text] [Related]
5. Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel.
Iusuf D; Hendrikx JJ; van Esch A; van de Steeg E; Wagenaar E; Rosing H; Beijnen JH; Schinkel AH
Int J Cancer; 2015 Jan; 136(1):225-33. PubMed ID: 24825069
[TBL] [Abstract][Full Text] [Related]
6. Modulation of OATP1B-type transporter function alters cellular uptake and disposition of platinum chemotherapeutics.
Lancaster CS; Sprowl JA; Walker AL; Hu S; Gibson AA; Sparreboom A
Mol Cancer Ther; 2013 Aug; 12(8):1537-44. PubMed ID: 23757163
[TBL] [Abstract][Full Text] [Related]
7. OATP1B1 polymorphism as a determinant of erythromycin disposition.
Lancaster CS; Bruun GH; Peer CJ; Mikkelsen TS; Corydon TJ; Gibson AA; Hu S; Orwick SJ; Mathijssen RH; Figg WD; Baker SD; Sparreboom A
Clin Pharmacol Ther; 2012 Nov; 92(5):642-50. PubMed ID: 22990751
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic effects of curcumin on docetaxel mediated by OATP1B1, OATP1B3 and CYP450s.
Sun X; Li J; Guo C; Xing H; Xu J; Wen Y; Qiu Z; Zhang Q; Zheng Y; Chen X; Zhao D
Drug Metab Pharmacokinet; 2016 Aug; 31(4):269-75. PubMed ID: 27452633
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations.
Hu S; Mathijssen RH; de Bruijn P; Baker SD; Sparreboom A
Br J Cancer; 2014 Feb; 110(4):894-8. PubMed ID: 24398510
[TBL] [Abstract][Full Text] [Related]
10. Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver.
van de Steeg E; Stránecký V; Hartmannová H; Nosková L; Hřebíček M; Wagenaar E; van Esch A; de Waart DR; Oude Elferink RP; Kenworthy KE; Sticová E; al-Edreesi M; Knisely AS; Kmoch S; Jirsa M; Schinkel AH
J Clin Invest; 2012 Feb; 122(2):519-28. PubMed ID: 22232210
[TBL] [Abstract][Full Text] [Related]
11. Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice.
Loos NHC; Ferreira Martins ML; Rijmers J; de Jong D; Lebre MC; Tibben M; Beijnen JH; Schinkel AH
Mol Pharm; 2024 Apr; 21(4):1952-1964. PubMed ID: 38423793
[TBL] [Abstract][Full Text] [Related]
12. Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging.
Nassif A; Jia J; Keiser M; Oswald S; Modess C; Nagel S; Weitschies W; Hosten N; Siegmund W; Kühn JP
Radiology; 2012 Sep; 264(3):741-50. PubMed ID: 22771883
[TBL] [Abstract][Full Text] [Related]
13. Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxel.
Smith NF; Acharya MR; Desai N; Figg WD; Sparreboom A
Cancer Biol Ther; 2005 Aug; 4(8):815-8. PubMed ID: 16210916
[TBL] [Abstract][Full Text] [Related]
14. Isolation of modulators of the liver-specific organic anion-transporting polypeptides (OATPs) 1B1 and 1B3 from Rollinia emarginata Schlecht (Annonaceae).
Roth M; Araya JJ; Timmermann BN; Hagenbuch B
J Pharmacol Exp Ther; 2011 Nov; 339(2):624-32. PubMed ID: 21846839
[TBL] [Abstract][Full Text] [Related]
15. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
[TBL] [Abstract][Full Text] [Related]
16. Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene.
Trdan Lušin T; Stieger B; Marc J; Mrhar A; Trontelj J; Zavratnik A; Ostanek B
J Transl Med; 2012 Apr; 10():76. PubMed ID: 22533838
[TBL] [Abstract][Full Text] [Related]
17. Selectivity and potency of microcystin congeners against OATP1B1 and OATP1B3 expressing cancer cells.
Niedermeyer TH; Daily A; Swiatecka-Hagenbruch M; Moscow JA
PLoS One; 2014; 9(3):e91476. PubMed ID: 24614281
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.
Durmus S; Lozano-Mena G; van Esch A; Wagenaar E; van Tellingen O; Schinkel AH
Mol Pharm; 2015 Dec; 12(12):4259-69. PubMed ID: 26474710
[TBL] [Abstract][Full Text] [Related]
19. Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3.
Gui C; Miao Y; Thompson L; Wahlgren B; Mock M; Stieger B; Hagenbuch B
Eur J Pharmacol; 2008 Apr; 584(1):57-65. PubMed ID: 18321482
[TBL] [Abstract][Full Text] [Related]
20. Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificity.
DeGorter MK; Ho RH; Leake BF; Tirona RG; Kim RB
Mol Pharm; 2012 Apr; 9(4):986-95. PubMed ID: 22352740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
